01.06.1999 | Original articles
Ex vivo expansion CD34+/AC133+ - selected autologous peripheral blood progenitor cells (PBPC) in high-risk breast cancer patients receiving intensive chemotherapy
Erschienen in: Hematology and Cell Therapy | Ausgabe 3/1999
Einloggen, um Zugang zu erhalten